Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SLDE | MBX |
|---|---|---|
| Price | $24.14 | $58.54 |
| Change today | ▲ 2.24% | ▲ 0.05% |
| Market cap | $2.82B | $2.82B |
| Return, 3 months | +16.5% | -5.6% |
| Return, year to date | +24.3% | +85.6% |
| Return, 1 year | +51.2% | +260.0% |
| P/E (TTM) | 5.0 | -24.7 |
| P/B | 2.4 | 6.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +36.5% | – |
| Net profit growth (YoY) | +120.7% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 38.4% | – |
| Return on equity | 57.4% | – |
| Analyst target vs. price | +5.2% | +69.6% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 55 | 46 |
| 30-day volatility | 38.8% | 47.8% |
| Max drawdown, 1 year | -20.0% | -37.6% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.